BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 27180906)

  • 1. SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.
    Kugel S; Sebastián C; Fitamant J; Ross KN; Saha SK; Jain E; Gladden A; Arora KS; Kato Y; Rivera MN; Ramaswamy S; Sadreyev RI; Goren A; Deshpande V; Bardeesy N; Mostoslavsky R
    Cell; 2016 Jun; 165(6):1401-1415. PubMed ID: 27180906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
    Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma.
    Wang Y; Li J; Guo S; Ouyang Y; Yin L; Liu S; Zhao Z; Yang J; Huang W; Qin H; Zhao X; Ni B; Wang H
    Oncotarget; 2017 Sep; 8(36):60414-60428. PubMed ID: 28947981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
    Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
    Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
    Yu J; Wu Y; Yang P
    J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
    Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
    Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality.
    Watanabe S; Shimada S; Akiyama Y; Ishikawa Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
    Int J Cancer; 2019 Jul; 145(1):192-205. PubMed ID: 30556125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCAF-mediated acetylation of Lin28B increases let-7 biogenesis in lung adenocarcinoma H1299 cells.
    Qu TT; Chen F; Wang J; Zhang YJ; Cheng MB; Sun WZ; Shen YF; Zhang Y
    BMC Cancer; 2018 Jan; 18(1):27. PubMed ID: 29301498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
    Busch B; Bley N; Müller S; Glaß M; Misiak D; Lederer M; Vetter M; Strauß HG; Thomssen C; Hüttelmaier S
    Nucleic Acids Res; 2016 May; 44(8):3845-64. PubMed ID: 26917013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
    Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
    Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirt6 inhibits vascular endothelial cell pyroptosis by regulation of the Lin28b/let-7 pathway in atherosclerosis.
    Yao F; Lv X; Jin Z; Chen D; Zheng Z; Yang J; Ren L; Wang B; Wang W; He J; Song Q; Gu J; Lin R
    Int Immunopharmacol; 2022 Sep; 110():109056. PubMed ID: 35978508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer.
    Demir IE; Ceyhan GO; Friess H
    Expert Opin Ther Targets; 2017 Jan; 21(1):1-3. PubMed ID: 27885875
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
    Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
    Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling.
    Guo J; Wang Z; Wu J; Liu M; Li M; Sun Y; Huang W; Li Y; Zhang Y; Tang W; Li X; Zhang C; Hong F; Li N; Nie J; Yi F
    Circ Res; 2019 May; 124(10):1448-1461. PubMed ID: 30894089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway.
    Alajez NM; Shi W; Wong D; Lenarduzzi M; Waldron J; Weinreb I; Liu FF
    Oncotarget; 2012 Dec; 3(12):1641-52. PubMed ID: 23482325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma.
    Wang C; Gu Y; Zhang E; Zhang K; Qin N; Dai J; Zhu M; Liu J; Xie K; Jiang Y; Guo X; Liu M; Jin G; Ma H; Jiang T; Yin R; Xia Y; Liu L; Wang S; Shen B; Huo R; Xu L; Sha J; Qu B; Shen H; Hu Z
    Oncogene; 2019 Mar; 38(10):1611-1624. PubMed ID: 30353165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity.
    Cai J; Zuo Y; Wang T; Cao Y; Cai R; Chen FL; Cheng J; Mu J
    Oncogene; 2016 Sep; 35(37):4949-56. PubMed ID: 26898756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
    Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
    Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.